Hilltop National Bank’s Marker Therapeutics MRKR Stock Holding History

Hilltop National Bank’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107	Hold	73	–	–	﹤0.01%	800
2026 Q1	$95	Hold	73	–	–	﹤0.01%	793
2025 Q4	$109	Hold	73	–	–	﹤0.01%	776
2025 Q3	$65	Hold	73	–	–	﹤0.01%	790
2025 Q2	$112	Buy	+73	New	+$94	﹤0.01%	788
2024 Q4	$227	Hold	73	–	–	﹤0.01%	771
2024 Q3	$206	Hold	73	–	–	﹤0.01%	810
2024 Q2	$396	Hold	73	–	–	﹤0.01%	811
2024 Q1	$314	Buy	+73	New	+$319	﹤0.01%	787

Other funds holding MRKR

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Hilltop National Bank's MRKR Position: Q2 2026 in Review

Hilltop National Bank held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 73 shares worth $107. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Hilltop National Bank first reported a position in MRKR in Q1 2024 and has held it in 9 quarters since. The position peaked at $396 in Q2 2024. 5 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

Hilltop National Bank held 73 shares of Marker Therapeutics worth $107 as of Q2 2026.
Hilltop National Bank left its Marker Therapeutics share count unchanged in Q2 2026.
Marker Therapeutics made up ﹤0.01% of Hilltop National Bank's portfolio in Q2 2026, its #800 holding.
Hilltop National Bank first reported a position in Marker Therapeutics in Q1 2024 and has held it in 9 quarters since.
Hilltop National Bank's Marker Therapeutics position peaked at $396 in Q2 2024.
5 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.